Fig. 1

Case 1: Changes in serum CA125 levels during therapy. After 10 months of resuming dienogest, bone mineral density measurements revealed normal bone density in the right hip joint (123%) and left hip joint (95%), but mild bone loss in the lumbar vertebrae (Lumbar 1–4: 79%), indicating the need for monitoring